2-methylene-19-nor-(23s)-25-dehydro-1 alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro1alpha-hydroxyvitamin D3-26,23-lactone

Details for Australian Patent Application No. 2006230296 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Deluca, Hector F.; Plum, Lori A.; Chiellini, Grazia; Grzywacz, Pawel; Clagett-Dame, Margaret

Agent Spruson & Ferguson

Pub. Number AU-B-2006230296

PCT Pub. Number WO2006/105221

Priority 60/666,129 29.03.05 US

Filing date 28 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 7 July 2011

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/105221 Priority application(s): WO2006/105221

7 July 2011 Application Accepted

  Published as AU-B-2006230296

3 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230308-Microprojections with capillary control features and method

2006230293-Contact lens package and applicator with method for its use